Johnson & Johnson MedTech

When lung cancer is found early, patients have a 63% 5-year survival rate, compared to 9% for those where cancer has spread to distant parts of their body1. The MONARCH? Platform, a robotically assisted bronchoscopy system, helps physicians confidently biopsy hard-to-reach lung nodules. To learn more about the MONARCH? Platform and important safety information, please visit: https://bit.ly/3USEG10 #LCAM2024 #RoboticBronchoscopy #LungCancerDiagnosis 1. National Institutes of Health. Cancer Stat Facts: Lung and Bronchus Cancer. https://bit.ly/4eQbEXM.

Congratulations to the team at Overlake Medical Center & Clinics on being the first hospital in the Eastside of Washington to offer the MONARCH? Platform. We proudly stand alongside you and share the enthusiasm to advance the future of lung cancer care for your community! To learn more about the MONARCH? Platform and important safety information, please visit: https://lnkd.in/gKDEMDAF

Our MONARCH? team recognizes the importance of building strong relationships, and we are there for our customers when they need us. Our commitment is unwavering – we support our customers because every minute matters for lung cancer patients. To learn more about the MONARCH? Platform and important safety information, please visit: https://bit.ly/3USEG10 #LCAM2024 #RoboticallyAssistedBronchoscopy #LungCancerDiagnosis

Meet Kyana Stewart, J&J MedTech U.S. Commercial Director for Innovation and Strategy. In that role, Kyana empowers surgeons at Ambulatory Surgery Centers (ASC) to better meet the needs of orthopaedic patients — and fuels her passion for driving progress in health equity and healthcare innovation.?? Want to make an impact like Kyana? Check out roles at J&J MedTech: https://lnkd.in/dERxdtc?

During #LCAM2024, we thank our #InterventionalPulmonologists and #ThoracicSurgeons who are changing the treatment paradigm for their lung cancer patients from “watch and wait” to “diagnose and treat” because they know every minute matters. To learn more about the MONARCH? Platform and important safety information, please visit: https://bit.ly/3USEG10 #RoboticallyAssistedBronchoscopy #LungCancerDiagnosis

Meet Edda Dupaquier, Field Sales, Advanced Hemostasis & Healing at Johnson & Johnson MedTech | Surgery. More than just a working parent of five—she’s an inspiring leader in her community, an expert in her field and a proud recipient of the 2024 “Working Parent of the Year” award at Johnson & Johnson.?? ? Read her inspiring story: https://lnkd.in/geG5i7nR #JnJMedTechProud?

#NEWS: Our OTTAVA? robotic surgical system will begin U.S. clinical trials after receiving Investigational Device Exemption (IDE) approval. OTTAVA features a unique unified architecture – which together with surgical instruments powered by Ethicon expertise and the Johnson & Johnson MedTech digital ecosystem is designed to set a new standard for the modern operating room. Congratulations to our teams who are shaping what’s next in surgery for surgeons, clinical teams, and patients around the world. Read the full announcement of this milestone: https://bit.ly/4fECbbc

#NEWS: We’re proud to announce U.S. FDA approval of our?VARIPULSE? Platform for the treatment of Atrial Fibrillation (#AFib).? ? With this approval, J&J MedTech will offer the first and only #PFA system in the U.S. that fully integrates with the CARTO? 3?Mapping System—allowing electrophysiologists to use a single, versatile workflow to help AFib patients get back to their normal lives. ? Thank you to our Johnson & Johnson MedTech | Electrophysiology teams who work alongside EPs to advance #Afib patient care across our product portfolio. ? Read the full announcement of this milestone:?https://bit.ly/3YFi1Hm

We are thrilled to have been recognized by the Gartner Eye on Innovation Awards for Healthcare & Life Sciences. Thanks to our teams across Johnson & Johnson MedTech whose collaboration made these achievements possible. ?? Winner in Life Sciences: AI Diagnosis and Care Pathway for Afib Patients earned the top honor for revolutionizing the diagnosis and management of atrial fibrillation through the power of AI, enhancing both precision and patient care. ??Runner-up in Life Sciences: TruMatch Scan2Health was recognized for its innovative approach to personalized healthcare, utilizing patient imaging to create custom surgical plans and manufacture tailored medical devices. Read more: https://gtnr.it/3YhmDDh #JnJMedTechProud

Meet Jose Prunet, a Workforce Management Analyst who ensures our Johnson & Johnson | Vision Customer Service team has everything they need to care for customers. Jose believes a fun environment always leads to inspiration, teamwork, and impact.? Whether he’s supporting J&J’s Hispanic Organization for Leadership and Achievement in their impressive efforts to provide underserved communities across the U.S. or taking center stage in his latest acting project, Jose consistently brings people together — making them smile and making a difference.?? Want to make an impact like Jose? Check out roles at J&J MedTech: https://lnkd.in/dERxdtc